Traders sold shares of Humana Inc. (NYSE:HUM) on strength during trading hours on Thursday. $502.66 million flowed into the stock on the tick-up and $526.62 million flowed out of the stock on the tick-down, for a money net flow of $23.96 million out of the stock. Of all stocks tracked, Humana had the 0th highest net out-flow for the day. Humana traded up $13.12 for the day and closed at $171.53

A number of research firms have recently commented on HUM. Cantor Fitzgerald reiterated a “buy” rating on shares of Humana in a report on Saturday, July 9th. Morgan Stanley reiterated a “hold” rating on shares of Humana in a report on Sunday, May 22nd. Stifel Nicolaus increased their price objective on Humana from $209.00 to $220.00 and gave the company a “buy” rating in a report on Thursday, May 5th. Royal Bank Of Canada increased their price objective on Humana from $209.00 to $220.00 and gave the company a “sector perform” rating in a report on Thursday, May 5th. Finally, Credit Suisse Group AG reiterated a “hold” rating on shares of Humana in a report on Thursday, May 5th. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating and six have given a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and an average target price of $205.00.

The company’s 50 day moving average is $176.89 and its 200-day moving average is $174.36. The firm has a market capitalization of $25.56 billion and a price-to-earnings ratio of 23.91.

Humana (NYSE:HUM) last released its quarterly earnings results on Wednesday, May 4th. The insurance provider reported $1.86 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.81 by $0.05. The business earned $13.80 billion during the quarter, compared to analyst estimates of $13.80 billion. The company’s revenue was down .2% compared to the same quarter last year. During the same quarter last year, the firm posted $2.58 EPS. Equities analysts anticipate that Humana Inc. will post $8.87 earnings per share for the current fiscal year.

Other hedge funds and institutional investors have added to or reduced their stakes in the company. Poplar Forest Capital LLC boosted its position in Humana by 1.1% in the fourth quarter. Poplar Forest Capital LLC now owns 9,100 shares of the insurance provider’s stock valued at $1,624,000 after buying an additional 100 shares during the period. Marshall Wace LLP boosted its position in Humana by 450.5% in the fourth quarter. Marshall Wace LLP now owns 171,008 shares of the insurance provider’s stock valued at $30,527,000 after buying an additional 139,942 shares during the period. Suntrust Banks Inc. boosted its position in Humana by 600.1% in the fourth quarter. Suntrust Banks Inc. now owns 10,264 shares of the insurance provider’s stock valued at $1,831,000 after buying an additional 8,798 shares during the period. Whitebox Advisors LLC boosted its position in Humana by 282.1% in the fourth quarter. Whitebox Advisors LLC now owns 250,507 shares of the insurance provider’s stock valued at $44,718,000 after buying an additional 184,940 shares during the period. Finally, Napier Park Global Capital US LP acquired a new position in Humana during the fourth quarter valued at approximately $5,355,000.

Humana Inc is a health and well-being company. The Company’s segments include Retail, Group, Healthcare Services and Other Businesses. The Retail segment consists of Medicare benefits, marketed to individuals or directly via group accounts, as well as individual commercial fully-insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.